Skip to content

Effects of Local Impregnation of Local Anesthetic Drugs Combined with Glucocorticoid on Analgesia after Parks I-type incision-thread-drawing procedure-A Prospective Randomized Controlled Trial

Effects of Local Impregnation of Local Anesthetic Drugs Combined with Glucocorticoid on Analgesia after Parks I-type incision-thread-drawing procedure-A Prospective Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16010055
Enrollment
Unknown
Registered
2016-11-30
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anal fistula pain

Interventions

Group A:Local Anesthetic Drugs Combined with Glucocorticoid

Sponsors

Beijing Er Long Road Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Complied with Parks type I anal fistula diagnostic criteria; 2) With informed consent of patients; 3) Aged 18 to 60 years; 4) Liver, kidney, heart, lung and bone marrow function were normal (HB male> 120g/L, female> 110g/L, PLT> 100× 10^9/L); 5) Patients without history of anal fistula surgery; 6) Patients without inflammatory bowel disease, pelvic floor radiation history; 7) Patients without history of long-term smoking, intravenous poison history, hepatitis, tuberculosis, AIDS and other infectious diseases.

Exclusion criteria

Exclusion criteria: 1) Patients with uncontrollable medical illnesses (including unstable angina, myocardial infarction, cerebrovascular accident within 6 months); 2) due to other organs of the body,patients can not accept anesthesia or surgical treatment; 3)Patients with 5-year history of malignant tumors; 4) Patients with uncontrolled epilepsy, central nervous system disease or mental disorder history; 5) Organ transplantation requires immunosuppressive therapy; 6) Patients with severe uncontrolled intestinal inflammatory disease, or other serious uncontrolled concomitant disease; 7) Patients with continuous systemic glucocorticoid hormone therapy; 8) Pregnant or lactating women of childbearing age; 9) Patients participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Verbal Numeric Rating Scale Pain Score;Hospital stay after operation ;Inpatients expenses;Infection;Reoperation;Complications;

Countries

China

Contacts

Public ContactLiancheng Liu

Beijing Er long Road Hospital

llcell@163.com+86 13601029226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026